A single blinded, randomized controlled trial comparing the efficacy and safety of 1% Luliconazole cream plus 1% CiclopiroxOlamine cream, 1% Luliconazole cream plus 0.25% Amorolfine cream and 1% Luliconazole cream alone in the treatment of Tinea Corporis and Tinea cruris.

SRM Medical College Hospital & Research Centre, SRMIST, Potheri0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年1月9日

研究概览

暂无简介。

•1. Patients of age 18years to 60 years, attending dermatology OPD of our hospital, and diagnosed to have Tinea corporis/cruris
•2. Positive KOH mount test from skin scraping
•3. Patients With mild to moderate extent of disease (less than 10% BSA involvement) and who are suitable for topical-only antifungal therapy.

•1.Patients with known allergy to azole antifungals, Amorolfine or Ciclopiroxolamine.
•2.Pregnancy/ lactation
•3.Patients with dermatophytosis affecting nails / scalp/ palms / soles
•4.Patients with clinical features suggestive of secondary bacterial infections
•5.Patients on immunosuppressive therapy
•6.Patients who had used any topical medications for the tinea corporis/cruris lesions, in the last 2 weeks, or any systemic antifungal medications in the last 1 month.
•7.Patients who are not willing to participate in the study.

发起方

SRM Medical College Hospital & Research Centre, SRMIST, Potheri